Specimen and Data Study for Ovarian Cancer Early Detection and Prevention

Recruiting Observational Study
Cervical Cancer Endometrial Cancer Fallopian Tube Cancer Hereditary Breast/Ovarian Cancer (brca1, brca2) Ovarian Cancer Sarcoma Uterine Leiomyomata Vaginal Cancer Vulvar Cancer
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 80
Sex
Female
Study type
Observational
Participants needed
6,000 (estimated)
Sponsor
Northwestern University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

RATIONALE: To improve strategies for detection and prevention of early-stage disease. PURPOSE: This research study is collecting specimens and data to develop better methods for early detection and prevention of ovarian cancer among the high risk population and those who have the disease.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
DISEASE CHARACTERISTICS: * Meets one of the following criteria: * Considered to be at increased risk for developing ovarian cancer, as defined by one of the following: * Has at least one first-degree relative (mother, sister, or daughter) with ovarian, primary peritoneal, or fallopian tube …
Contacts

Takelia Walker

3125034802

takelia-watson@northwestern.edu

CONTACT

Anne Grace

312-503-4165

anne@northwestern.edu

CONTACT